# Pfizer Covid Pill Revenue Plunges 95%. That’s Just One Reason the Stock Is Slipping.

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-04 15:29 UTC · Category: Business · Sources: 8 · Current Velocity: 6.36

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioPharma Dive | Pfizer expands multibillion-dollar cost-cutting plan | 2026-08-04 21:27 | [Source Link](https://news.google.com/rss/articles/CBMijAFBVV95cUxNRDR3Tk95Y20xbHBaUGJLdWQyNVp4aDdUUU9UcW1wenl6N2xHY0g1aFBOd01xcEFmU3FkTy01Mm44UnhjdTBxNFpTZmRkeEdwaG1hYmxkQTBrUWhsNmViMm1PYjFkXzI1R0s4UHBUMlJUTzdMV1BCVXpfZDFtSFJKaUljbXVNN1d3Q2trWQ?oc=5) |
| Yahoo Finance | Compared to Estimates, Pfizer (PFE) Q2 Earnings: A Look at Key Metrics | 2026-08-04 21:27 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxPRGg0czJjaHlDYWdRN19pZkgxUFJfTy1KOVZkNHJmRHhBVVZ5YWd4Q052cHZuQlJlaE5MalNNekRrYzNVdUVvQkxBaHBsZGZLZk1KS3J3LXhuY0JEblhaX1RJTDZFbUtNRlZjS0xtcXQ2SEViN0dQdndhOHhGRm9scHVzaWZ6U1lDU0tKMzJUS3VRRGppVnN6Wg?oc=5) |
| Yahoo Finance | Pfizer’s (NYSE:PFE) Q2 CY2026: Beats On Revenue | 2026-08-04 14:19 | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxNSGFZV3hIVEd5VC00b01RN3pSMmhKdkhzUEV1TW1PaUV4SlZpeDBSNTBlUl9DZDhJQjZQaGo0V28tTmswUTVXRWtBMXBva1pueURGRXFZcHpxWVl5bFhKbGhwQm9zTHkwSE42MnM1OEdZbG5JQ21GV3V0UjlCM2xueDhKODZWc0JwWUhKQkkxZw?oc=5) |
| Fierce Pharma | Pfizer unveils additional $2.5B in planned cost savings through 2029 | 2026-08-04 14:19 | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxOUXJsSnprM3RMcmcyYzRkLVJvYUctNHM0VEtTSkhXRV9CREV5TjdYZWdOa2hSMy1JMUoxVWV2WG5mWXBJYjNTZTNoQWJ2bXM0N2R2ZnI2Mk5aYTY3ejQ5Ulk0d01BWEdzRWZJaklhcmlfdnByYkxpYjdmcXdpNnJQSzIya2lRUmVab3JEeGRDSUpzcHpnTFFsUk9HTGlmV1RN?oc=5) |
| bloomberg.com | Pfizer Raises Sales Guidance on High Demand for Older Drugs | 2026-08-04 14:19 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxOMGVMMUU2bHd6RWF0ck44LVFuMFY2czBSM3ptZFpuMXVKZWFRRlp4VVVCazZVbzI5Qng2U2FMc3pnSjRMWHpoRFZ1S1Z3QjdveDdRUGpLdS0xWUdHdF9SSWxySFlaX09yWlhaaFZBU2xtRHdTZmlVUVRYQkhQYnRnd250NzlEaGE5N0tBeDhrWkhzTkdTRWVYQm4wVVl1NlEtdUhaOC1LLVA5dUdrdDR4OXlB?oc=5) |
| Reuters | Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts | 2026-08-04 14:19 | [Source Link](https://news.google.com/rss/articles/CBMi4AFBVV95cUxQM3lmMk85dldqOW03S0ZkeHhNdGRJelJuSVh5cHI4ZWo1d2tpclRZdEhicVBVZ0pwMnlrTElVWmdxQjYtMjhvY2FWXzBLdGszVWt2OUtBZ1dMU3l5cUdOcFFJcUhTWUoteTFzVUc4Q2wzZFRaUENia19ocGVuSnRYa0prUWU2VDhxc3NrMXVyZ0VSeTFERDFBMkVuNk00RkVZaXAxSW1SRTVEdjBDbGFveDhVUm9HQUZ0d3NWQXUycHFJZmpFNFNJTlRUcnVWMmhzY041SmVIb2FZeWY5UWRhSA?oc=5) |
| WSJ | Pfizer’s Quarterly Results Beat Expectations on Cancer, Heart Drugs | 2026-08-04 14:19 | [Source Link](https://news.google.com/rss/articles/CBMiiAFBVV95cUxQME5WbUlyNm5jZUxGVE1FZmlhRHVlcGZfdW1ITFAyMVk3b3Z4alVCOFZEQWlkTjExaWZNNlIxX2g2RWI0aFU1Q1NOUzRrS3R3NzBYX2ZBZ1lxVENlU1JuOVdORk4wZENYZnRjcjFKaVRPdTlaZWZyODBJNVFubzJFMjVzczFzd041?oc=5) |
| CNBC | Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs | 2026-08-04 14:19 | [Source Link](https://news.google.com/rss/articles/CBMickFVX3lxTFAyUngzLXBKNWFqQ3VWUHlSQVFzTzQ2cS13NmRWUFVmc25NVFI0MmVia2tsczUwS0JZY1cxcXlfdVpHbVRCLUFfVnhaVjl4VEd4R0FRZnJzdm1vYWNOSDF0VFVmSHhKRWtOTjRQcmxpZHNXUdIBd0FVX3lxTFBvWF9oQXJIUkpyVkFhU1REdTFqY2hQVzRMUmpNdjljUTJGWjl5UmVaa0xSdjBUZmJ0akRqaDlyMWxNUmQtTzBQR0FJVDZZbm9raDNtbW1idjdESEFnZm1wTzRBUHNOQ0VtcmM3aS1MOFVqZXNMT3FF?oc=5) |
| Barron's | Pfizer Covid Pill Revenue Plunges 95%. That’s Just One Reason the Stock Is Slipping. | 2026-08-04 14:19 | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxNNXEtc2UxQnNVc2QxR2VhQ3daSGpGeVlocVJ5eEhJTHg1N0pjWXlnenFDLURHR3hvMXNwTzlUR1BoSm5mOXhodkU3NjJVNS1JZUI5S2N4TmM1Q0VTZENOR3lOWW4zWlRCVzFLUkctSDBGZ25ZV2RWOGdKNXY2LXRLRkNFWEw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-04/pfizer-covid-pill-revenue-plunges-95-that-s-just-one-reason-the-stock-is*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*